HOME >> BIOLOGY >> NEWS
Patients' cells from tumors, the immune system merged for customized cancer therapy

One of the strongest natural allies that cancer patients can tap to help fight tumor growth and metastasis may well be their own immune systems, and scientists affiliated with the Harvard University Medical School have devised ways of bolstering patients' immune response against kidney and breast cancer.

In a paper published in the July 15 issue of the journal Clinical Cancer Research, the Harvard research team documented tumor regression in two breast cancer patients, and stabilization and containment of tumor growth in late stage breast and kidney patients through application of customized vaccinations made from the patients' own tumor and immune system cells.

By fusing patients' tumor cells with their immune system dendritic cells, researchers associated with the laboratory of Donald Kufe, M.D., professor of medicine at Dana-Farber Cancer Institute and Harvard Medical School, created customized antigen-presenting immune cells that train T cells to hunt, recognize and destroy the patients' tumor cells.

"We aimed to develop a novel vaccine that took whole tumor cells with their complete array of tumor-specific antigens and combine them with the potent immune stimulating machinery of the dendritic cells," said David Avigan, M.D., director of bone marrow transplantation at Beth Israel Deaconess Medical Center, and the lead author of the Clinical Cancer Research article.

The immune system develops T cells, which are white blood cells, to recognize foreign proteins, cells, and other matter that causes disease or infection. Tumor cells produce proteins, carbohydrates and other molecules that are different than the healthy cells that are normally found in the human body. The immune system can recognize cancer-related molecules, but cancer cells often are difficult for the immune system to detect. Conversely, dendritic cells are potent immune stimulating cells capable of generating the type of T Cells that attack and kill cancer
'"/>

Contact: Russell Vanderboom
vanderboom@aacr.org
215-440-9300
American Association for Cancer Research
15-Jul-2004


Page: 1 2 3 4

Related biology news :

1. First Study To Take Bacteria Directly From Patients Mouths Further Supports Possible Link Between Gum And Heart Disease
2. Preclinical safety study shows adipose-derived stem cells improve heart function after heart attack
3. Researchers develop fast track way to discover how cells are regulated
4. Chemical signals health of brain cells Symposium
5. New dye directly reveals activated proteins in living cells
6. NJIT professor receives Presidential Award for breakthrough research with adult stem cells
7. Complex cells likely arose from combination of bacterial and extreme-microbe genomes
8. Smac-ing back at cancer cells
9. Bone marrow cells routinely help with wound healing
10. Genuine stem cells found in skin might treat hair loss, wounds
11. Skin stem cells give hairless mice hair

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/22/2018)... ... December 21, 2018 , ... On ... the Boston Healthcare Drinks event featuring Helen Chen, Greater China Managing Partner of ... The discussion was moderated by patent attorney David J. Dykeman , co-chair ...
(Date:12/18/2018)... ... December 18, 2018 , ... ... artificial intelligence into client marketing. The technology has been effective at reducing patient ... Cell has been working with clients nationwide on patient acquisition marketing programs. Traditional ...
(Date:12/13/2018)... , ... December 12, 2018 , ... ... Vinod Shah, one of the firm’s prominent Expert Consultants, was recently honored by ... award recognizes leaders who are working in pharmaceutical science, technology, engineering, or education ...
Breaking Biology News(10 mins):
(Date:1/8/2019)... ... ... The American Society of Gene and Cell Therapy’s (ASGCT) first ... up of industry leaders identified by the ASGCT board of directors. In total, the ... support ASGCT members designing transformative pilot studies in gene and cell therapy as they ...
(Date:1/4/2019)... ... January 04, 2019 , ... ... Ted Hoffman to the firm. Ted will be joining the firm as a ... and providing consulting services to the pharmaceutical industry. At Triangle Insights, Ted will ...
(Date:1/4/2019)... ... 2019 , ... CellMax Life , a diagnostics company ... been named as a partner in Medigen Biotech’s upcoming cell therapy clinical trials. ... treatment, will use CellMax Life’s circulating tumor cell platform CMxTM, in combination with ...
(Date:12/20/2018)... ... 20, 2018 , ... New Year’s brings reflection and desire to improve for ... European Union (EU) on the horizon, Jim Kasic, president and CEO of Boulder iQ, ... EU Medical Device Regulation (MDR), digital health, and big data are just a few ...
Breaking Biology Technology:
Cached News: